The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medications

por Carty, N C, Xu, J, Kurup, P, Brouillette, J, Goebel-Goody, S M, Austin, D R, Yuan, P, Chen, G, Correa, P R, Haroutunian, V, Pittenger, C, Lombroso, P J
Publicado 2012

Inhibition of STEP(61) ameliorates deficits in mouse and hiPSC-based schizophrenia models

por Xu, J, Hartley, B J, Kurup, P, Phillips, A, Topol, A, Xu, M, Ononenyi, C, Foscue, E, Ho, S-M, Baguley, T D, Carty, N, Barros, C S, Müller, U, Gupta, S, Gochman, P, Rapoport, J, Ellman, J A, Pittenger, C, Aronow, B, Nairn, A C, Nestor, M W, Lombroso, P J, Brennand, K J
Publicado 2018